USFDA concludes audit at Jeevan Scientific Technology’s Hyderabad centre

24 Apr 2019 Evaluate

United States Food and Drug Administration (USFDA) has concluded the audit at Jeevan Scientific Technology’s clinical pharmacology centre, Hyderabad. The auditors started the review on April 15, 2019 and completed on April 24, 2019. The audit is completed with NIL Observation (i.e. zero 483 observation), signifying that best practices were followed, in compliance to applicable regulations.

Jeevan Scientific Technology provides a range of clinical research services for healthcare/pharmaceutical industries in India and internationally. Its clinical research services comprise bio-analytical, clinical data management, biostatistics and statistical programming, medical writing, pharmacovigilance, regulatory affairs, quality assurance, and project management services, as well as clinical operation and scientific writing services.

Jeevan Scientific Share Price

62.68 -0.02 (-0.03%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
TCS 3238.90
Infosys 1615.95
HCL Tech. 1682.85
Wipro 260.00
Tech Mahindra 1569.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×